https://www.afinalwarning.com/497161.html (Natural News) A 28-year-old healthcare worker from the Swedish American Hospital, in Beloit, Wisconsin was recently admitted to the ICU just five days after receiving a second dose of Pfizer’s experimental mRNA vaccine. The previously healthy young woman was pronounced brain dead after cerebral angiography confirmed a severe hemorrhage stroke in her brain stem.
Her family members confirmed that she was “breaking out in rashes” after the vaccine. She also suffered from sudden migraine headaches, and got “sick” after taking the second dose of the vaccine. At the very end, she lost the ability to speak and went unconscious. The migraines, nausea, and loss of speech were all symptoms of a brain bleed and brain swelling, something her family did not understand at the time, and something nobody would expect after vaccination.
Understanding the molecular biology of brain tumors is key to prognosis and treatment said Le Bonheur Neuroscience Institute Co-Director Frederick Boop, MD, in his presentation How Molecular Biology Impacts Clinical Practice at the International Society for Pediatric Neurosurgery (ISPN) 2020 Virtual Meeting.
Credit: Ichia Chen
A University of Sydney-led international team of scientists has revealed the shape of one of the most important molecular machines in our cellsthe glutamate transporter, helping to explain how our brain cells communicate with one another.
Glutamate transporters are tiny proteins on the surface of all our cells that shut on and off the chemical signals that have a big role in making sure all cell-to-cell talk runs smoothly. They are also involved in nerve signalling, metabolism and learning and memory.
The researchers captured the transporters in exquisite detail using cryogenic electron microscopy (cryo-EM), showing they look like a twisted elevator embedded in the cell membrane.
E-Mail
The brain s neural activity is irregular, changing from one moment to the next. To date, this apparent noise has been thought to be due to random natural variations or measurement error. However, researchers at the Max Planck Institute for Human Development have shown that this neural variability may provide a unique window into brain function. In a new Perspective article out now in the journal
Neuron, the authors argue that researchers need to focus more on neural variability to fully understand how behavior emerges from the brain.
When neuroscientists investigate the brain, its activity seems to vary all the time. Sometimes activity is higher or lower, rhythmic or irregular. Whereas averaging brain activity has served as a standard way of visualizing how the brain works, the irregular, seemingly random patterns in neural signals have often been disregarded. Strikingly, such irregularities in neural activity appear regardless of whether single neurons or entire br
Amyloid deposits in the brain increase the risk of dementia and strokes. Researchers at Washington University School of Medicine in St. Louis have identified an antibody that clears amyloid deposits from the brain without raising the risk of brain bleeds.